(Q28193107)
Statements
Safety and efficacy of only 2 weeks of ticlopidine therapy in patients at increased risk of coronary stent thrombosis: results from the Antiplatelet Therapy alone versus Lovenox plus Antiplatelet therapy in patients at increased risk of Stent Thrombosis (ATLAST) trial (English)
0 references
May 2002
0 references
143
0 references
5
0 references
841-6
0 references